Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly Signs Cardiovascular Research Partnership With India’s Zydus Cadila

This article was originally published in The Pink Sheet Daily

Executive Summary

Deal worth a potential $300 million in milestone payments gives Lilly option to license up to six cardiometabolic or dyslipidemia compounds.
Advertisement

Related Content

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2009
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q1 2009
Eli Lilly Global External R&D Director Yetunde Taiwo On Partnering Plans For Discovery Research: An Interview With PharmAsia News
India’s Jubilant, Eli Lilly In Joint Venture To Develop Molecules

Topics

Advertisement
UsernamePublicRestriction

Register

PS069214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel